Ellevest, Inc. Tandem Diabetes Care Inc Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$35.86 - $46.5 $4,482 - $5,812	-125 Reduced 66.14%	64 $2,000
Q4 2022 Feb 03, 2023	BUY	$35.49 - $56.15 $3,726 - $5,895	105 Added 125.0%	189 $8,000
Q3 2022 Nov 02, 2022	SELL	$43.76 - $68.97 $218 - $344	-5 Reduced 5.62%	84 $4,000
Q2 2022 Jul 18, 2022	BUY	$53.22 - $123.09 $2,661 - $6,154	50 Added 128.21%	89 $5,000
Q1 2022 Apr 19, 2022	SELL	$101.89 - $150.09 $1,630 - $2,401	-16 Reduced 29.09%	39 $5,000
Q4 2021 Jan 24, 2022	SELL	$118.18 - $153.21 $709 - $919	-6 Reduced 9.84%	55 $8,000
Q3 2021 Oct 19, 2021	BUY	$93.51 - $129.4 $5,704 - $7,893	61 New	61 $7,000

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.